Laboratory of Translational Imaging in Oncology (U1288)

The laboratory of Translational Imaging in Oncology (LITO) is a mixed research unit (U1288) created on 1/1/2020 and supported by Inserm (=French NIH) and Institut Curie, the 1st cancer center in France.  LITO includes about 40 researchers, physicists, engineers, MDs, PharmDs, technologists and trainees, and is organized in two research groups with complementary activities:

• The Biomarkers for Phenotype Imaging group develops and evaluates novel radiotracers and new molecular and functional imaging protocols, using Positron Emission Tomography (PET), Computed Tomography (CT), Magnetic Resonance (MR) and Ultrasound Imaging (US), for cancer applications.
• The Integrated Radiomics for Precision Medicine group develops original quantification and image analysis methods, including using Artificial Intelligence approaches, to extract the most precise and comprehensive information from medical images, and combines the imaging features with other types of data (clinical, biological, pathological, etc) to assist decision support.

More on lito-web